BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Burnette EM, Nieto SJ, Grodin EN, Meredith LR, Hurley B, Miotto K, Gillis AJ, Ray LA. Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder. Drugs 2022. [PMID: 35133639 DOI: 10.1007/s40265-021-01670-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Stokłosa I, Więckiewicz G, Stokłosa M, Piegza M, Pudlo R, Gorczyca P. Medications for the Treatment of Alcohol Dependence—Current State of Knowledge and Future Perspectives from a Public Health Perspective. IJERPH 2023;20:1870. [DOI: 10.3390/ijerph20031870] [Reference Citation Analysis]
2 Bach P, de Timary P, Gründer G, Cumming P. Molecular Imaging Studies of Alcohol Use Disorder. Curr Top Behav Neurosci 2023. [PMID: 36639552 DOI: 10.1007/7854_2022_414] [Reference Citation Analysis]
3 Agabio R, Saulle R, Rösner S, Minozzi S. Baclofen for alcohol use disorder. Cochrane Database Syst Rev 2023;1:CD012557. [PMID: 36637087 DOI: 10.1002/14651858.CD012557.pub3] [Reference Citation Analysis]
4 Wang X, Li L, Bian C, Bai M, Yu H, Gao H, Zhao J, Zhang C, Zhao R. Alterations and correlations of gut microbiota, fecal, and serum metabolome characteristics in a rat model of alcohol use disorder. Front Microbiol 2022;13:1068825. [PMID: 36687619 DOI: 10.3389/fmicb.2022.1068825] [Reference Citation Analysis]
5 Haass-Koffler CL, Francis TC, Gandhi P, Patel R, Naemuddin M, Nielsen CK, Bartlett SE, Bonci A, Vasile S, Hood BL, Suyama E, Hedrick MP, Smith LH, Limpert AS, Roberto M, Cosford NDP, Sheffler DJ. Development and use of a high-throughput screen to identify novel modulators of the corticotropin releasing factor binding protein. SLAS Discov 2022;27:448-59. [PMID: 36210051 DOI: 10.1016/j.slasd.2022.09.005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Metz VE, Leibowitz A, Satre DD, Parthasarathy S, Jackson-Morris M, Cocohoba J, Sterling SA. Effectiveness of a pharmacist-delivered primary care telemedicine intervention to increase access to pharmacotherapy and specialty treatment for alcohol use problems: Protocol for the alcohol telemedicine consult cluster-randomized pragmatic trial. Contemp Clin Trials 2022;123:107004. [PMID: 36379437 DOI: 10.1016/j.cct.2022.107004] [Reference Citation Analysis]
7 Gatta E, Camussi D, Auta J, Guidotti A, Pandey SC. Neurosteroids (allopregnanolone) and alcohol use disorder: From mechanisms to potential pharmacotherapy. Pharmacol Ther 2022;240:108299. [PMID: 36323379 DOI: 10.1016/j.pharmthera.2022.108299] [Reference Citation Analysis]
8 Anderson PO. Drugs for Treating Alcohol Use Disorder During Lactation. Breastfeeding Medicine 2022;17:872-874. [DOI: 10.1089/bfm.2022.0241] [Reference Citation Analysis]
9 Corsi M, Veltri A, Perretta S, Marino R, Necciari G, Caldi F, Foddis R, Cristaudo A, Buselli R, Guglielmi G. A Medical Resident with a History of Alcohol Abuse and Suicidal Ideation: A Challenge for Both Psychiatry and Occupational Medicine in the Context of the First Wave of the COVID-19 Pandemic. Case Rep Psychiatry 2022;2022:7396453. [PMID: 36299477 DOI: 10.1155/2022/7396453] [Reference Citation Analysis]
10 Fischler PV, Soyka M, Seifritz E, Mutschler J. Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review. Front Pharmacol 2022;13:927703. [DOI: 10.3389/fphar.2022.927703] [Reference Citation Analysis]
11 Kokhan VS, Chaprov K, Ninkina NN, Anokhin PK, Pakhlova EP, Sarycheva NY, Shamakina IY. Sex-Related Differences in Voluntary Alcohol Intake and mRNA Coding for Synucleins in the Brain of Adult Rats Prenatally Exposed to Alcohol. Biomedicines 2022;10:2163. [DOI: 10.3390/biomedicines10092163] [Reference Citation Analysis]
12 Cantero-garcía N, Flores-burgess A, Pineda-gómez JP, Orio L, Serrano A, Díaz-cabiale Z, Millón C. Galanin N-terminal fragment (1−15) reduces alcohol seeking and alcohol relapse in rats: Involvement of mesocorticolimbic system. Biomedicine & Pharmacotherapy 2022;153:113508. [DOI: 10.1016/j.biopha.2022.113508] [Reference Citation Analysis]
13 Casali L, Mazzei L, Sun R, Chierotti MR, Gobetto R, Braga D, Grepioni F, Ciurli S. Thiocarbamoyl Disulfides as Inhibitors of Urease and Ammonia Monooxygenase: Crystal Engineering for Novel Materials. Crystal Growth & Design. [DOI: 10.1021/acs.cgd.2c00439] [Reference Citation Analysis]
14 Dinis-oliveira RJ. The Genesis of a New Open-Access Journal Focused on the Latest Scientific Advances in Psychoactive Substances. Psychoactives 2022;1:1-6. [DOI: 10.3390/psychoactives1010001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Getachew B, Csoka AB, Tizabi Y. Dihydromyricetin Protects Against Ethanol-Induced Toxicity in SH-SY5Y Cell Line: Role of GABAA Receptor. Neurotox Res 2022. [PMID: 35386023 DOI: 10.1007/s12640-022-00503-9] [Reference Citation Analysis]
16 Al Neimat KSY, Alserhany AK, Alanazi ME, Alanazi AA, Alanazi NE, Alanazi MA, Almulhim FA, Alazmi IA, Alanazi AQ, Alsharari AS, Alsharari MM, Aldaham DA, Alazmi NH. Updates in Prevalence, Risk Factors, Management and Outcome of Treatment of Acute Pancreatitis. Pharmacophore 2022;13:1-7. [DOI: 10.51847/tyrk6xbcye] [Reference Citation Analysis]